Henlius Partners with Switzerland’s Sandoz to Launch Global Biosimilar Strategic Collaboration — BigGo Finance
Fosun Pharma (02196.HK), through its controlled subsidiary Henlius (02696.HK), announced on August 16, 2026, that it has entered…
Fosun pays $32M to join Lilly and Novartis in fiercely competitive psoriasis market
A Fosun Pharma subsidiary has paid Junshi Biosciences 215 million yuan ($32 million) for Chinese rights to a near-approval…